Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Beverly Moy Suzette Delaloge Marc Buyse Vernon Harvey Bent Ejlertsen Hiroji Iwata Norikazu Masuda Gunter von Minckwitz Michael Gnant Arlene Chan |
| Publication date | March 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |